The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Behrs Melissa Kelly since 2006.
The trader's CIK number is 1187032.
At the time of the last reporting, Behrs Melissa Kelly was the SVP Oncology of Geron Corp. (stock ticker symbol GERN).
Also see all insider trading activities at Geron Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | GERN | 0 | $0 | 120,635 | $241,270 | 0 | $0 |
| 2015 | GERN | 0 | $0 | 2,380 | $9,139 | 0 | $0 |
| 2014 | GERN | 0 | $0 | 17,136 | $36,354 | 0 | $0 |
| 2013 | GERN | 0 | $0 | 28,292 | $46,568 | 0 | $0 |
| 2012 | GERN | 0 | $0 | 18,910 | $25,906 | 0 | $0 |
| 2011 | GERN | 0 | $0 | 28,237 | $121,419 | 0 | $0 |
| 2010 | GERN | 0 | $0 | 12,953 | $69,586 | 0 | $0 |
| 2009 | GERN | 0 | $0 | 32,722 | $223,795 | 0 | $0 |
| 2008 | GERN | 0 | $0 | 32,756 | $144,156 | 0 | $0 |
| 2006 | GERN | 0 | $0 | 8,441 | $72,254 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-04-09 | GERN | Sale | 120,635 | 2.00 | 241,270 |
| 2015-05-29 | GERN | Sale | 2,380 | 3.84 | 9,139 |
| 2014-05-29 | GERN | Sale | 4,826 | 2.10 | 10,134 |
| 2014-04-01 | GERN | Sale | 12,310 | 2.13 | 26,220 |
| 2013-01-17 | GERN | Sale | 28,292 | 1.65 | 46,568 |
| 2012-05-30 | GERN | Sale | 18,910 | 1.37 | 25,906 |
| 2011-06-14 | GERN | Sale | 25,262 | 4.28 | 108,121 |
| 2011-05-24 | GERN | Sale | 2,975 | 4.47 | 13,298 |
| 2010-06-02 | GERN | Sale | 10,617 | 5.43 | 57,650 |
| 2010-05-24 | GERN | Sale | 2,336 | 5.11 | 11,936 |
| 2009-05-29 | GERN | Sale | 2,277 | 6.35 | 14,458 |
| 2009-05-26 | GERN | Sale | 6,819 | 6.75 | 46,028 |
| 2009-02-02 | GERN | Sale | 14,765 | 8.12 | 119,891 |
| 2009-01-05 | GERN | Sale | 8,861 | 4.90 | 43,418 |
| 2008-11-05 | GERN | Sale | 23,845 | 4.05 | 96,572 |
| 2008-01-04 | GERN | Sale | 8,911 | 5.34 | 47,584 |
| 2006-01-09 | GERN | Sale | 8,441 | 8.56 | 72,254 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Behrs Melissa Kelly (SVP Oncology of Geron Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.